Molecular Cloning of Human Phosphomevalonate Kinase and Identification of a Consensus Peroxisomal Targeting Sequence*

Two overlapping cDNAs which encode human liver phosphomevalonate kinase (PMKase) were isolated. The human PMKase cDNAs predict a 191-amino acid protein with a molecular weight of 21,862, consistent with previous reports for mammalian PMKase (Mr = 21,000-22,500). Further verification of the clones was obtained by expression of PMKase activity in bacteria using a composite 1024-base pair cDNA clone. Northern blot analysis of several human tissues revealed a doublet of transcripts at approximately 1 kilobase (kb) in heart, liver, skeletal muscle, kidney, and pancreas and lower but detectable transcript levels in brain, placenta, and lung. Analysis of transcripts from human lymphoblasts subcultured in lipid-depleted sera (LDS) and LDS supplemented with lovastatin indicated that PMKase gene expression is subject to regulation by sterol at the level of transcription. Southern blotting indicated that PMKase is a single copy gene covering less than 15 kb in the human genome. The human PMKase amino acid sequence contains a consensus peroxisomal targeting sequence (PTS-1), Ser-Arg-Leu, at the C terminus of the protein. This is the first report of a cholesterol biosynthetic protein which contains a consensus PTS-1, providing further evidence for the concept that early cholesterol and nonsterol isoprenoid biosynthesis may occur in the peroxisome.

[1]  M. Toth,et al.  Molecular Cloning and Expression of the cDNAs Encoding Human and Yeast Mevalonate Pyrophosphate Decarboxylase (*) , 1996, The Journal of Biological Chemistry.

[2]  C. Weinberger A model for farnesoid feedback control in the mevalonate pathway , 1996, Trends in Endocrinology & Metabolism.

[3]  P. Edwards,et al.  Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Krisans,et al.  Compartmentalization of Cholesterol Biosynthesis , 1996, The Journal of Biological Chemistry.

[5]  Suresh Subramani,et al.  How proteins penetrate peroxisomes , 1995, Cell.

[6]  I. Shechter,et al.  Molecular Cloning and Functional Analysis of the Promoter of the Human Squalene Synthase Gene (*) , 1995, The Journal of Biological Chemistry.

[7]  H. Moser,et al.  Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders , 1995, Nature Genetics.

[8]  C. Slaughter,et al.  Molecular Cloning of the Mature NAD-dependent Succinic Semialdehyde Dehydrogenase from Rat and Human , 1995, The Journal of Biological Chemistry.

[9]  P. Edwards,et al.  Farnesyl-diphosphate synthase is localized in peroxisomes. , 1994, The Journal of biological chemistry.

[10]  K. Wirtz,et al.  The non-specific lipid-transfer protein (sterol carrier protein 2) and its relationship to peroxisomes. , 1993, Biochimie.

[11]  J. Ericsson,et al.  Isoprenoid biosynthesis in rat liver peroxisomes. Characterization of cis-prenyltransferase and squalene synthetase. , 1992, The Journal of biological chemistry.

[12]  K. Gibson,et al.  Molecular cloning of human mevalonate kinase and identification of a missense mutation in the genetic disease mevalonic aciduria. , 1992, The Journal of biological chemistry.

[13]  G. Robinson,et al.  Cloning and characterization of ERG8, an essential gene of Saccharomyces cerevisiae that encodes phosphomevalonate kinase , 1991, Molecular and cellular biology.

[14]  H. Rennert,et al.  Cloning and expression of a cDNA encoding human sterol carrier protein 2. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Mohler,et al.  Molecular cloning of mevalonate kinase and regulation of its mRNA levels in rat liver. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Tanaka,et al.  Purification and regulation of mevalonate kinase from rat liver. , 1990, The Journal of biological chemistry.

[17]  Thomas J. White,et al.  PCR protocols: a guide to methods and applications. , 1990 .

[18]  K. Gibson,et al.  Mevalonate kinase in lysates of cultured human fibroblasts and lymphoblasts: kinetic properties, assay conditions, carrier detection and measurement of residual activity in a patient with mevalonic aciduria. , 1989, Enzyme.

[19]  J. Iglesias,et al.  Influence of cholestyramine feeding on mevalonate-activating enzymes. , 1988, Enzyme.

[20]  D. González-Pacanowska,et al.  Quantitative role of different embryonic tissues in mevalonate metabolism by sterol and nonsterol pathways. Relationship with enzyme activities of cholesterogenesis. , 1986, Biochimica et biophysica acta.

[21]  D. González-Pacanowska,et al.  Effects of different nutritional conditions on chick liver mevalonate-activating enzymes. , 1986, Biochimica et biophysica acta.

[22]  W. O'Sullivan,et al.  Improved procedures for the synthesis of phosphomevalonate and for the assay and purification of pig liver phosphomevalonate kinase. , 1985, Biochimica et biophysica acta.

[23]  A. M. Jabalquinto,et al.  The effect of diabetes, nutritional factors, and sex on rat liver and kidney mevalonate kinase, mevalonate-5-phosphate kinase, and mevalonate-5-pyrophosphate decarboxylase. , 1981, Archives of biochemistry and biophysics.

[24]  J. Eyzaguirre,et al.  Pig liver phosphomevalonate kinase. 1. Purification and properties , 1980 .

[25]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Porter,et al.  The inhibition of mevalonic kinase by geranyl and farnesyl pyrophosphates. , 1968, The Journal of biological chemistry.